Related Experiment Video
Updated: Aug 29, 2026

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
Published on: March 15, 2024
The management of Peyronie's disease
1St Peter's Hospitals and The Institute Of Urology, London, UK. dralph@andrology.co.uk
Abstract:
Peyronie's disease has no known cause; recent understanding of the molecular mechanisms involved and the development of an animal model will aid the medical management of early disease. The medical management of chronic disease is futile as the delicate tunical architecture cannot regenerate. Surgical correction of the penile deformity is required in a minority of patients, and a choice lies between a Nesbit operation and a plaque incision and venous patch in patients who are concerned with penile shortening.
Insights
Peyronie's disease lacks a clear cause, but understanding its molecular basis and using animal models can improve early treatment. Chronic cases are untreatable, requiring surgery for penile deformities.
Area of Science:
- Urology
- Molecular Biology
- Animal Modeling
Background:
- Peyronie's disease etiology remains unknown.
- Current medical management for chronic Peyronie's disease is ineffective due to irreversible tunical damage.
- Surgical intervention is necessary for a subset of patients with significant penile deformity.
Purpose of the Study:
- To explore the molecular mechanisms underlying Peyronie's disease.
- To develop an animal model for studying Peyronie's disease.
- To improve the medical management of early-stage Peyronie's disease.
Main Methods:
- Investigation of molecular pathways involved in Peyronie's disease pathogenesis.
- Development and validation of a preclinical animal model.
- Review of treatment options for chronic Peyronie's disease.
Main Results:
- Understanding molecular mechanisms offers potential for early disease intervention.
- An established animal model facilitates research into disease progression and treatment efficacy.
- Chronic Peyronie's disease management is limited, with surgery being the primary option.
Conclusions:
- Advances in understanding molecular mechanisms and animal modeling are crucial for improving early Peyronie's disease management.
- Medical treatment for chronic Peyronie's disease is not viable.
- Surgical options like the Nesbit operation or plaque incision with venous grafting are available for patients concerned about penile shortening.
More Related Videos
03:55Urethroplasty with Pedicled Tunica Vaginalis for the Treatment of Long-segment Anterior Urethral Stricture Caused by Lichen Sclerosus of Glans Penis
Published on: October 18, 2024
04:22Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Atherosclerosis III: Management
Angina IV: Management